معرفی
Wei Zhang is a Postdoctoral Research Fellow in the School of Natural Sciences at Macquarie University, currently engaged in cancer biomarker research using small extracellular vesicles (sEVs). His work bridges nanotechnology, oncology, and diagnostic engineering, with a focus on translating laboratory discoveries into clinical applications for early cancer detection.
His academic foundation includes:
- PhD in Molecular Science, Macquarie University (2018-2023), specializing in cancer-derived sEVs as biomarkers and therapeutic vehicles
Dr. Zhang's research centers on developing surface-enhanced Raman spectroscopy (SERS) techniques for detecting cancer biomarkers on sEVs, particularly for pancreatic and breast cancer diagnosis. He has pioneered SERS-based assays for liquid biopsy and engineered hybrid vesicle-liposome systems for targeted gene therapy. His methodology integrates nanomaterials science with clinical oncology to create point-of-care diagnostic tools.
Analysis of his 30+ publications (2020-2025) reveals three dominant trajectories: (1) SERS-microfluidic integration for portable cancer diagnostics, (2) aptamer-amplification strategies for ultra-sensitive exosome quantification, and (3) biomimetic drug delivery systems using engineered sEVs. These efforts consistently target translational oncology with emphasis on breast, pancreatic, and ovarian cancers.
His scientific contributions have been recognized through competitive awards:
- Macquarie University Research Training Program (MQRTP) (2018)
- Macquarie University Postgraduate Research Fund (PGRF) (2019)
- Research Scholar Award from Sydney Vital Translational Cancer Research Centre (2020)
- Vice Chancellor’s Commendation for Academic Excellence (2023)
Dr. Zhang secured research funding for the project 'Glycan profiling of cancer derived small extracellular vesicles for cancer diagnostics using SERS nanotags' (2020-2021). His work demonstrates significant industry relevance, evidenced by pre-PhD experience at Shanghai and US Aucta pharmaceuticals. While no formal students are listed, his research has garnered 423 citations and attracted media attention from multiple news outlets.
His laboratory work operates within Macquarie University's interdisciplinary nanomedicine ecosystem, collaborating with oncology clinicians and microfluidics engineers. The research leverages core facilities for spectroscopy, nanofabrication, and cancer biology, with recent publications indicating partnerships with international institutions in China and the United States.
